Photo taken from Weill Cornell Medicine/X
Sep 22, 2024, 03:28
New hope for metastatic melanoma patients – Weill Cornell Medicine Meyer Cancer
Weill Cornell Medicine Meyer Cancer Center shared a post by Weill Cornell Medicine on X, adding the following:
“Check out the latest research from WCM Meyer Cancer Director Dr. Jedd Wolchok and colleagues, providing hope for patients with metastatic melanoma.”
Quoting Weill Cornell Medicine’s post:
“About half of patients with metastatic melanoma treated with a combo of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to new trial findings led by WCM Meyer Cancer, Dana Farber, and Royal Marsden NHS.
Source: Weill Cornell Medicine Meyer Cancer Center/X and Weill Cornell Medicine/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 18:52
Mar 30, 2025, 18:31
Mar 30, 2025, 17:19